General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cohen–Wolkowiez M et al. – Dosage guidelines for newer antifungal agents are currently based on adult and limited pediatric data. Because important developmental pharmacology changes occur throughout childhood impacting the pharmacokinetics of these agents, antifungal studies specifically designed for children are necessary.

Related Articles

Update on pediatric lung allocation in the United States
Pediatric Transplantation, 10/20/09    Relevance Score: 93%

Pediatric Inflammatory Bowel Disease: Highlighting Pediatric Differences in IBD
Gastroenterology Clinics of North America, 11/13/09    Relevance Score: 92%

Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09    Relevance Score: 92%

B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients
Arthritis & Rheumatism, 11/04/09    Relevance Score: 91%

Prioritizing neurosurgical education for pediatricians: results of a survey of pediatric neurosurgeons
Journal of Neurosurgery: Pediatrics, 10/13/09    Relevance Score: 91%

Today in Antimicrobials...keeping you current

Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09

Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Annals of Pharmacotherapy, 11/25/09

Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
Annals of Pharmacotherapy, 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address